Evaluating the effectiveness of vitamin D in managing PMS symptoms in adolescent girls with primary dysmenorrhea Текст научной статьи по специальности «Клиническая медицина»

Литература:

1. Osendarp S.J., Murray-Kolb L.E., Black M.M. Case study on iron mental development - in memory of John Beard (1947-2009). Nutr Rev. 2010; 68 (1): 48-52.

2. Васильева Т.М., Захарова И.Н., Заплатников А.Л., Лазарева С.И., Мачнева Е.Б. Алгоритм диагностики и лечения железодефицитных состояний. Электронный ресурс. ttps://www.rmj.ru/articles/pediatriya/Algoritm_diagnostiki_ilecheniya_ghel ezodeficitnyh_sostoyaniy_udetey/#ixzz8Yy6eefKq.

3. Орынханова М.О., Жанузаков М.А. Особенности железодефицитной анемии у студентов и методы ее коррекции. Наука о жизни и здоровье. 2019;19: 86-93.

4. Жорова В.Е., Хилькевич Е.Г. Частота и распространенность железодефицитной анемии. Электронный ресурс. fNe:///D:/Downloads/chastota-i-rasprostranennost-zhelezodefitsitnoy - anemii.pdf.

5. Железодефицитнaя анемия: скрининг, профилактика и лечение. Клинический протокол для всех уровней здравоохранения. Бишкек-2023. Электронный ресурс. https://diseases.medelement.com/ disease.

EVALUATING THE EFFECTIVENESS OF VITAMIN D IN MANAGING

PMS SYMPTOMS IN ADOLESCENT GIRLS WITH PRIMARY

DYSMENORRHEA

Kulzhanova D.S.1, Amanzholkyzy A.1

1NJSC «West Kazakhstan Marat Ospanov Medical University», Aktobe, Republic of Kazakhstan

kulzhanova.dinara@bk. ru

Relevance. Existing research on premenstrual syndrome (PMS) in adolescent girls and young women suggests the use of various dietary supplements before menstruation to alleviate PMS symptoms. However, alongside studies reporting positive effects of vitamin D, there are also studies that do not confirm such associations. Further research is needed to elaborate and confirm the effectiveness or ineffectiveness of vitamin D intake, to demonstrate the possible required dosage of vitamin D, and to assess the long-term effectiveness of vitamin D intake.

Objective. The aim of this study was to evaluate the effect of vitamin D on PMS characteristics in adolescent girls with primary dysmenorrhea.

Materials and Methods. The study included 191 adolescent girls with PD. Participants were randomly divided into two groups: the main

group receiving vitamin D and the control group receiving placebo. At the beginning and after three months of the study, all girls were surveyed to identify PMS symptoms and determine the level of 25(OH) vitamin D in the blood serum.

Results. Among the examined adolescent girls with PD and PMS, more than 70% were characterized by vitamin D deficiency. In the main group, a statistically significant increase in vitamin D content was found after the study (p < 0.001). At the beginning, the prevalence of PMS among adolescent girls with PD in the main group was 51.7%, and after taking vitamin D, this value decreased to 23% (p < 0.001). In the control group, cases of PMS increased from 35% to 42.5% in the sequence before and after taking the placebo.

Conclusion. Vitamin D intake for three months significantly improves the studied PMS symptoms among adolescent girls with primary dysmenorrhea, and also significantly improves the course of the menstrual cycle, in particular, by normalizing the duration of menstruation in days and the abundance of discharge.

References.

1. Bahrami A. et al. The Prevalence of Menstrual Problems amongst Adolescent Girls in Northeastern Iran //Journal of Advances in Medical and Biomedical Research. - 2022. - Т. 30. - №. 138. - С. 61-68. https://doi.org/10.30699/jambs.30.e55702

2. Alicia C. Jarosz, Ahmed El-Sohemy, Association between Vitamin D Status and Premenstrual Symptoms, Journal of the Academy of Nutrition and Dietetics, Volume 119, Issue 1, 2019, Pages 115-123, ISSN 2212-2672, https://doi.org/10.1016/jjand.2018.06.014.

ВОЗМОЖНОСТИ САНАТОРНО-КУРОРТНОГО ЛЕЧЕНИЯ В КОРРЕКЦИИ КЛИНИКО-ФУНКЦИОНАЛЬНОГО СОСТОЯНИЯ

БОЛЬНЫХ С ХОБЛ

Суйшдк К-Б.

НАО "Медицинский университет Астана", "НИИ профилактической медицины имени академика Е.Д.Даленова" г.Астана, Республика Казахстан

пи. бэ1епоу@_эти. кг

Хроническая обструктивная болезнь легких (ХОБЛ) остается одним из крупнейших вызовов для мирового здравоохранения. По данным Всемирной Организации Здравоохранения, ХОБЛ занимает третье место среди причин смертности в мире, унеся жизни 3,23